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Electrophysiological Evidence of Early Functional
Damage in Glaucoma and Ocular Hypertension
Rachel V. North, Adrian L. Jones, Neville Drasdo, John M. Wild, and James E. Morgan
PURPOSE. The quantification of early retinal ganglion cell dam-
age in ocular hypertension and glaucoma.
METHODS. Thirty subjects under treatment for open-angle glau-
coma, 23 subjects with ocular hypertension, and 28 healthy
subjects in a control group were investigated by monocular
pattern electroretinogram (ERG), L&M (long and medium
wavelength) cone ERG, and S (short wavelength)-cone ERG.
The diagnosis of glaucoma was based on masked assessment of
digital stereoscopic optic nerve head images by three glaucoma
specialists. The optic nerve head and retinal nerve fiber layer
was assessed by scanning laser ophthalmoscopy and optical
coherence tomography.
RESULTS. All types of ERG had reduced mean amplitudes in
ocular hypertension and open-angle glaucoma groups com-
pared with the control group. In the ocular hypertension
group, the N95 and the L&M-pathway photopic negative re-
sponse (PhNR) were significantly attenuated (by 19% and 18%
compared with the control group, respectively; by 30% and
22%, respectively, in the open-angle glaucoma group com-
pared with the control group). In the subjects with open-angle
glaucoma, the pattern ERG P50-N95 was found to be the most
sensitive electrophysiological test, and the cup–disc area ratio,
when examined by scanning laser ophthalmoscopy, was the
most sensitive imaging parameter. Modest but not statistically
significant correlations were found between the imaging and
electrophysiologic parameters.
CONCLUSIONS. With disc appearance used for the classification
of open-angle glaucoma and ocular hypertension, significant
electrophysiological losses were found in both conditions. The
modest correlation between the structural and electrophysio-
logical measures suggests that these assess different aspects of
the pathologic process; electrophysiology can be used to quan-
tify retinal ganglion cell dysfunction that occurs before cell
death. (Invest Ophthalmol Vis Sci. 2010;51:1216–1222) DOI:
10.1167/iovs.09-3409
There is now compelling evidence that, in glaucoma, retinalganglion cells undergo a prolonged period of dysfunction
and degeneration before cell loss.1–5 These changes are mani-
fested structurally as remodeling and pruning of the dendritic
tree1,3,4 and functionally as a reduction in neuronal sensitivi-
ty.2–6 On their own, these changes would generate a discrep-
ancy in clinical measures of the relationship between visual
field loss and changes in retinal structure similar to those
reported.7–10 Electrophysiological measurements from retinal
ganglion cells in experimental glaucoma show reduced respon-
sivity in both the spatial and temporal domains.2 It is likely
therefore that these changes underlie the reduction in sensi-
tivity in glaucoma, but further confirmatory work is needed.
Studies have shown that neuroretinal rim loss occurs before
visual field loss7–10 and that visual field loss correlates better
with ganglion cell loss in the more advanced stages of glauco-
ma.10 One explanation for the apparent nonlinear relationship
between structure and function is that it is an artifact resulting
from the logarithmic (decibel) scaling of the visual field. A
linear relationship is found between the 1/lambert differential
light threshold and the temporal neuroretinal rim area.11 These
observations do not exclude the possibility that reductions in
sensitivity also reflect cell dysfunction as well as cell loss,2,4
which would imply a discrepancy between structure and func-
tion.
The discrepancies between clinical measures of structure
and function depend on the particular measures being com-
pared and their sensitivity and specificity. It would be ex-
pected that at the molecular level, the structure and function
would be highly correlated. Therefore, with higher-resolution
tools and comparable scales of structure and function a perfect
correlation may be achieved.
We reasoned that a more sensitive measure of retinal gan-
glion cell integrity would be provided by electrophysiological
measures of retinal ganglion cell function (pattern electroreti-
nogram; PERG),12–27 photopic negative response (PhNR)28–32)
compared with other functional (perimetric) or structural mea-
sures. If this is the case, we would expect to find reductions in
electrophysiological responses in eyes that are predisposed to
retinal ganglion cell loss and in eyes with early structural
damage, but with little in the way of visual field loss. We have
used complimentary measures of retinal ganglion cell function
(PERG, L&M [long and medium wavelength]- and S [short
wavelength]-pathway PhNR). Although these measures are sen-
sitive indicators of neural damage, they relate to different
pathways and to different areas of the retina. We included an
assessment of the integrity of the S-pathway in view of the
reported sensitivity to glaucoma.31,33–36
In this study, we tested the hypothesis that electrophysio-
logical defects are present in the retina in patients with early
structural damage and little or no perimetric loss. Data in
support of this would be consistent with a sequence of retinal
ganglion cell damage similar to that reported in experimental
models of glaucoma.
METHODS
Healthy control subjects and patients with early stages of open-angle
glaucoma and ocular hypertension (OHT) were recruited. The study
adhered to the tenets of the Declaration of Helsinki and was approved
by the BroTaf Health Authority (Wales, UK). All subjects gave informed
consent.
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Patients with Open-Angle Glaucoma and OHT
Patients were recruited from the eye clinics at the University Hospital
of Wales (Cardiff, UK). All patients underwent a routine clinical exam-
ination including optic nerve head assessment by slit lamp binocular
indirect ophthalmoscopy, gonioscopy, perimetry (Humphrey Field An-
alyzer, Program 24-2 and SITA Fast Algorithm), and Goldmann appla-
nation tonometry. Intraocular pressure measures were not corrected
for corneal thickness. Stereophotographs of the optic nerve head were
obtained with a stereoscopic fundus camera (3Dx; Nidek Inc., Pasa-
dena, CA). All patients had normal color vision (Ishihara plates) and
visual acuity of 20/30 or better in both eyes. Exclusion criteria were
history of ocular (including refractive) surgery, other ocular diseases,
use of systemic steroids or -blockers, and a mean deviation (MD)
greater than 6 dB. All participants in the study were in good general
health. One eye was included in the study, and the nondominant eye
was chosen if both eyes were eligible.
Digitized disc images of all participants were viewed stereoscopi-
cally with an IBM-compatible computer with a quad-buffered display
and Z-screen (Stereographics Corp., San Rafael, CA). The optic nerve
head status of each subject was assessed in a masked fashion by a panel
of three ophthalmologists trained to fellowship standard in glaucoma
(with agreement defined as two of three). The subjective assessment
was based on standard clinical criteria for the diagnosis of glaucoma-
tous damage, which included the presence of vertical saucerization,
focal thinning (notching), and vertical asymmetry of the neuroretinal
rim, loss of physiological rim shape, disc margin hemorrhage(s), and
peripapillary atrophy.37 Classification of the subjects was made accord-
ing to the stereoscopic optic nerve head images and untreated intraoc-
ular pressure. Subjects were grouped in the following manner: (1)
open-angle glaucoma if glaucomatous optic neuropathy was present
and the untreated IOP was 21 mm Hg; (2) ocular hypertensive if the
optic nerve head appeared healthy and the untreated IOP was21 mm
Hg (on at least two consecutive occasions); and (3) control if the optic
nerve head appeared healthy and the IOP  21 mm Hg.
Healthy Subjects
An age-matched group of healthy subjects was recruited from friends
or spouses of the patients attending the hospital and staff at Cardiff
University. Inclusion criteria were visual acuity of 20/30 or better,
intraocular pressure of less than 21 mm Hg, no ophthalmic disease, and
no family history of glaucoma in a first-degree relative. Perimetric status
was examined (Humphrey Field Analyzer, Program 24-2 and the SITA
Fast algorithm; Carl Zeiss Meditec, Inc.). All subjects had undergone
perimetry on at least one occasion. One eye was included in the study;
the nondominant eye was chosen if both eyes were eligible.
Electroretinography
PERGs and ERGs were recorded monocularly. DTL electrodes were
placed in the lower fornix and a 9-mm silver electrode placed close to
the outer canthus for an ipsilateral temporal reference. A silver elec-
trode at the midfrontal position, served as the ground. The unstimu-
lated eye was patched throughout the recordings. PERGs were re-
corded with a 19-minute black-and-white checkerboard pattern
stimulus, reversing four times per second (square wave reversal) at a
95% contrast. The stimuli were generated on a monitor subtending 24°
 16° at a viewing distance of 80 cm. The stimuli covered the whole
screen, which was 35-cm wide and 27-cm high.31 Each patient was
refracted and viewed the checkerboard with an appropriately adjusted
refractive correction. The pupil was then dilated to a minimum diam-
eter of 7 mm with 2.5% phenylephrine and either 0.5% or 1% tropic-
amide. The L&M-pathway ERG was recorded to a 5-ms flash of red light
(650 nm) at 50 cd  m2 on a continuous blue background (450 nm) at
2.7 cd  m2 (2000 scotopic trolands), with a miniature Ganzfeld
stimulator containing colored LEDs.31 The responses were recorded at
a frequency of 1.8 Hz. The S-pathway ERG was recorded with a silent
substitution technique.31 To achieve photometric balance, blue light
(450 nm, 24 cd  m2) and green (535 nm) light were superimposed
and flickered at 33 Hz on a red (650 nm) continuous background. The
luminance of the green light was then adjusted until the patient no
longer perceived the flicker. At this frequency, rods and S-cones do not
contribute significantly, and the balance is presumed to correct for the
M-cones. When the frequency is reduced to 1.67 Hz, the S-cones
respond, and the M-cones remain silent. The L-cone response is sup-
pressed by the continuous red background at 108 cd  m2 and the rod
response is saturated at the intensities used (2000 scotopic trolands).
Optic Nerve Head Imaging
The OCT uses low-coherence interferometry to provide measures of
retinal thickness. Three circular scans with a radius of 1.74 mm cen-
tered on the midpoint of the optic nerve head were acquired by OCT
(Humphrey OCT Model 2000 with software version A5.0; Carl Zeiss
Meditec, Inc.).38 The OCT provides 100 axial scans along the scan
profile line, and the image acquisition was achieved in approximately
1 second per scan. An arbitrarily color-coded image is generated from
which estimates of the global retinal nerve fiber layer (RNFL) and the
global full retinal thickness (FRT) are made by proprietary algorithms.
Global measures are the average of the 100 points along each circular
scan.
Three 10° images centered on the optic disc were acquired (Hei-
delberg Retina Tomograph [HRT]; Heidelberg GmbH, Heidelberg, Ger-
many).39 The HRT uses a 670-nm wavelength diode laser and a confo-
cal imaging system to provide topographic measures of the optic nerve
head and peripapillary retina. The acquisition time for each image was
approximately 1.67 seconds. Off-line, the HRT software aligned the
three images and created a mean topographic image for further anal-
ysis. A contour line was then manually placed along the optic nerve
head margin as defined by the location of Elschnig’s ring. From this,
topographic parameters including the disc area; cup depth, area and
volume; neural retinal rim area; and RNFL thickness were calculated
(HRT software version 2.01b; Heidelberg Engineering) according to
the standard reference plane by a research optometrist (AJ). All these
parameters provide information about the disc structure and take into
account the three-dimensional shape of the neuroretinal rim and optic
cup.
Data Analysis and Statistics
All electrophysiology traces were characterized by two negative and
one positive deflection in the order N1, P1, and N2 (Fig. 1). The PERG
P50 was measured from N1 to P1, the P50-N95 from P1 to N2, and the
N95 from baseline. The a-wave (N1) of the L&M- and S-pathway ERGs
was measured from the baseline, the b-wave (P1) from baseline, and
the PhNR from baseline to N2 and also from P1 to N2 (peak to peak).
Between-subject group comparisons were made with either the Stu-
dent’s t-test or the Mann-Whitney U test, depending on the distribution
of the data. A receiver operating characteristic (ROC) analysis was
performed for each test to determine the area under the ROC curve
(SPSS V11.0 software; SPSS Inc., Chicago, IL).
RESULTS
Subject characteristics are shown in Table 1 with all subjects
classified as open-angle glaucoma, OHT, or control, according
to optic nerve head appearance and untreated IOP. The open-
angle glaucoma group comprised 30 subjects (14 men and 16
women); the OHT group, 23 subjects (13 men and 10 women);
and the control group, 28 subjects (12 men and 16 women).
All subjects in the open-angle glaucoma group and 11 of the
OHT subjects were receiving oculohypotensive therapy. Com-
pared with the control group, the IOP was significantly higher
in the open-angle glaucoma and OHT groups and the visual
field indices were significantly different in the open-angle glau-
coma group.
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Electrophysiology
ERG amplitudes are summarized in Table 2. There were no
significant differences in the implicit times of the various ERG
components for either the open-angle glaucoma or OHT
groups compared with the control subjects, and therefore they
have not been included. Both groups showed reduced ampli-
tudes for each ERG when compared to the control group.
Pattern ERG. The N95 amplitude was significantly reduc-
tion in the OHT group, but the P50-N95 provided slightly
better discrimination from the controls with an ROC area of
0.70.The open-angle glaucoma subjects showed significantly
smaller PERG amplitudes compared to the control subjects.
Although there was similar attenuation of both the P50 and
N95, the P50-N95 amplitude provided the best discrimination
between the groups with an ROC area score of 0.79. The ROC
area varied between 0.70 and 0.79 and 0.63 and 0.70 for the
various electrophysiological parameters of the open-angle glau-
coma and OHT group, respectively.
L&M-Pathway. The PhNR from the L&M-pathway ERG was
significantly reduced in both groups. The b-wave was also
significantly reduced in the open-angle glaucoma group. The
ROC area varied between 0.63 and 0.75 and 0.57 and 0.71 for
the various electrophysiological parameters in the open-angle
glaucoma and OHT group, respectively.
S-Pathway. Of the S-pathway measures, the PhNR was the
only statistically reduced parameter in the open-angle glau-
coma group compared with the control subjects, with a mod-
est ROC area score of 0.60.
The ROC area varied from 0.56 to 0.61 and from 0.55 to
0.63 for the various electrophysiological parameters in the
open-angle glaucoma and OHT group, respectively.
Imaging
A summary of the imaging data is shown in Table 3. All HRT
parameters (except RNFL thickness, disc area) were signifi-
cantly different between the open-angle glaucoma and the
control group. No significant differences were found between
any of the parameters of the OHT and control group. The OCT
global RNFL thickness was significantly reduced in the open-
angle glaucoma group compared with the control group.
Global FRT was significantly reduced in both the open-angle
glaucoma and OHT group (Fig. 2).
Effect of Oculohypotensive Treatment in OHT
Of the 23 subjects with OHT, 11 subjects were being treated
with pressure-lowering topical drops. The IOP was 24.81 mm
Hg (SEM 0.78) and 19.17 mm Hg (SEM 1.52) in the untreated
and treated groups, respectively. There were no significant
differences between the imaging parameters in either the
treated or untreated group compared with the control group.
None of the electrophysiological parameters was reduced in
the treated group, but the PERG N95, P50-N95 and L&M-
pathway PhNR were significantly reduced in the untreated
group compared with the control group (Table 4).
The correlation between the imaging and electrophysiolog-
ical parameters are shown in Table 5. When ERG parameters
were compared, the highest correlation found was between
the PERG P50-N95 and the L&M-pathway PhNR (r  0.453,
P  0.00002).
FIGURE 1. Examples of electrophysiological traces for (a) PERG, (b)
L&M-cone ERG, and (c) S-cone ERG.
TABLE 1. Details of Sample Construction
Control (n  28)
Open Angle Glaucoma
(n  30)
Ocular Hypertension
(n  23)
Mean SEM Mean SEM Mean SEM
Age, y 59.36 1.70 60.70 1.82 60.17 1.68
Sphere, DS 0.20 0.35 0.68 0.34 0.27 0.74
Cylinder, DC 0.52 0.12 0.44 0.08 0.73 0.14
IOP, mm Hg 14.20 0.28 19.87 0.33 22.11 0.41
MD, dB 0.14 0.12 1.89 0.36 0.85 0.16
PSD, dB 1.81 0.12 3.39 0.88 1.97 1.01
Bold data indicate a significant difference versus the control group (P  0.05).
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DISCUSSION
The major finding of our study is that there was a deficit in
electrophysiological measurement of ganglion cell function in
subjects with OHT. In addition, we found deficits in the bipolar
and ganglion cell function in patients with early open-angle
glaucoma with no or minimal visual field loss.
The mean amplitudes of all the electrophysiological pa-
rameters were reduced in both the OHT and open-angle
glaucoma group compared with the control group. Of the 11
parameters measured, the majority (7/11) were significantly
reduced in the open-angle glaucoma group compared with
those in the OHT group (2/11). In the OHT group, the N95
was the only significantly attenuated PERG parameter, with
a 19% reduction compared with 30% in the open-angle
glaucoma group. The L&M-pathway PhNR was also signifi-
cantly attenuated, being reduced by 18% compared with
22% in the open-angle group. A similar reduction of the
PhNR amplitude has been reported by our group, using a
long-duration flash (200 ms).32 These findings are consistent
with less damage or dysfunction in the OHT group than in
the open-angle glaucoma group.
In the open-angle glaucoma group, the PERG P50-N95
amplitude was statistically the most affected electrophysio-
logical parameter that provided the greatest discriminatory
power. This result is not surprising, as the PERG has been
shown to be sensitive to diffuse loss, and it has been hy-
TABLE 2. ERG Parameters
Control Ocular Hypertension Open Angle Glaucoma
Mean SEM Mean SEM
%
Change P
ROC
Area Mean SEM
%
Change P
ROC
Area
PERG
P50, V 1.95 0.19 1.55 0.16 21 0.118 0.628 1.38 0.13 29 0.014 0.685
N95, V 1.71 0.15 1.38 0.12 19 0.027 0.682 1.20 0.12 30 0.002 0.733
P50-N95, V 3.65 0.30 2.93 0.26 20 0.063 0.702 2.57 0.15 30 0.002 0.787
L&M-pathway ERG
a-Wave, V 9.24 0.59 8.41 0.56 9 0.321 0.574 7.86 0.48 15 0.076 0.632
b-Wave, V 23.29 1.82 19.68 2.02 16 0.190 0.634 17.66 1.67 24 0.026 0.670
PhNR, V
(baseline–trough)
16.12 0.92 13.17 0.82 18 0.023 0.711 12.53 1.23 22 0.001 0.746
PhNR, V (peak
to peak)
39.42 2.50 32.85 2.66 17 0.079 0.655 30.19 2.02 23 0.006 0.725
S-pathway ERG
a-Wave, V 1.50 0.35 1.15 0.12 23 0.548 0.550 1.02 0.12 32 0.175 0.607
b-Wave, V 1.15 0.31 0.73 0.19 36 0.460 0.561 0.79 0.27 31 0.458 0.557
PhNR, V
(baseline–trough)
4.44 0.61 3.42 0.21 23 0.262 0.594 3.26 0.36 27 0.041 0.602
PhNR, V (peak
to peak)
5.68 0.87 4.15 0.25 27 0.133 0.625 4.05 0.37 29 0.064 0.603
Bold data indicate a significant difference versus the control group (P  0.05). % Change is in comparison with the control group.
TABLE 3. Imaging Parameters
Control Ocular Hypertensions Open-Angle Glaucoma
Mean SEM Mean SEM
%
Change P
ROC
Area Mean SEM
%
Change P
ROC
Area
HRT
Disc area, mm2 1.90 0.10 1.79 0.06 6 0.583 0.455 1.89 0.07 0 0.565 0.544
Cup Area, mm2 0.50 0.09 0.49 0.05 3 0.364 0.575 0.95 0.07 89 0.000003 0.860
Cup-disc area
ratio
0.24 0.03 0.27 0.02 10 0.188 0.608 0.50 0.02 100 0.0000005 0.886
NNR area, mm2 1.35 0.09 1.22 0.09 10 0.318 0.551 0.94 0.05 30 0.0002 0.802
Cup volume,
mm3
0.11 0.03 0.09 0.02 20 0.670 0.535 0.31 0.05 177 0.000003 0.858
NNR volume,
mm3
0.35 0.03 0.35 0.03 2 0.879 0.552 0.24 0.03 32 0.0004 0.770
Cup depth, mm 0.18 0.02 0.21 0.01 10 0.409 0.571 0.34 0.02 78 0.0000002 0.880
Max cup depth,
mm
0.52 0.04 0.56 0.4 7 0.496 0.547 0.75 0.03 43 0.00001 0.796
CSM 0.20 0.20 0.17 0.01 14 0.068 0.650 0.09 0.01 55 0.000002 0.866
RNFL thickness,
mm
0.22 0.01 0.23 0.02 6 0.566 0.463 0.19 0.01 12 0.158 0.620
OCT
Global RNFL
thickness, m
122.42 2.44 116.25 2.31 5 0.076 0.649 104.66 3.44 15 0.0001 0.780
Global FRT, m 296.83 19.27 260.87 10.29 12 0.016 0.615 252.51 11.86 15 0.003 0.725
Bold data indicate a significant difference versus the control group (P  0.05). % Change is in comparison with the control group.
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pothesized that open-angle glaucoma commences with a
diffuse defect.40 Although other studies have shown higher
discriminatory values, these differences may be explained
by the more advanced nature of the glaucoma of the subjects
who participated, with mean MDs being 4.04 dB20 and
3.22 dB32 compared with 1.89 dB in the present study.
In agreement with previous studies, the most significantly
affected flash ERG parameter was the PhNR of the brief-stim-
ulus L&M-pathway flash ERG.28,29 The significant attenuation
of the L&M-pathway ERG b-wave implies that there may dam-
age to the bipolar cells in the distal retina. Further evidence of
bipolar dysfunction is provided by the OCT measurements and
a recent histologic analysis in human glaucoma reporting neu-
ronal loss in the outer retinal layers.41 The b-wave deficits for
the L&M- and S-pathways are nearly identical with those of the
PhNR. This finding is contrary to that of Viswanathan et al.29
who found that the b-wave was not significantly reduced in
patients with open-angle glaucoma. However, similar deficits
in these electrophysiological measures have been previously
reported by our group31 and both studies have found the
b-wave to be less sensitive than the PhNR in distinguishing
healthy from glaucomatous eyes. This topic requires further
investigation to understand the differences reported.
A significant reduction was found of both the RNFL thick-
ness and the FRT (full retinal thickness) of the open-angle
glaucoma group as measured by the OCT, the percentage
difference in each parameter being approximately the same.
There is some debate as to the accuracy of the OCT measure-
ment of RNFL thickness. Compared with histologic measure-
ments made from postmortem human eyes,42,43 the OCT con-
sistently underestimates RNFL thickness.44 Nevertheless, our
results imply a reduction of retinal thickness that may occur
not only due to a loss of retinal ganglion cells and their axons,
but also due to a loss of other retinal cells and/or their pro-
cesses. There may be a loss of the somas in the retinal ganglion
cell layer and thinning of the inner plexiform layer. In this
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FIGURE 2. FRT and RNFL layer thickness measurements (mean and SEM) by OCT in the control and open-angle glaucoma group. T, temporal; S,
superior; N, nasal; I, inferior disc location.
TABLE 4. ERG Parameters in Subjects with OHT According to Treatment Status
Treated OHT Untreated OHT Treated OHT Untreated OHT
Mean SEM Mean SEM % Change P % Change P
PERG
P50, V 2.23 0.67 1.43 0.24 14 0.417 27 0.116
N95, V 1.56 0.75 1.22 0.10 9 0.532 29 0.004
P50-N95, V 2.50 0.24 2.64 0.28 11 0.425 28 0.047
L&M-pathway ERG
a-Wave, V 9.60 0.73 7.32 0.73 4 0.731 21 0.068
b-Wave, V 22.03 3.35 17.53 2.31 5 0.726 25 0.077
PhNR, V (baseline–trough) 14.01 1.48 12.40 0.80 13 0.231 23 0.018
PhNR, V (peak to peak) 36.04 4.52 29.93 2.91 9 0.493 24 0.033
S-pathway ERG
a-Wave, V 1.22 0.20 1.09 0.15 18 0.894 28 0.414
b-Wave, V 0.79 0.27 0.68 0.28 31 0.596 41 0.516
PhNR, V 3.24 0.27 3.59 0.31 27 0.207 19 0.572
PhNR, V (peak to peak) 4.03 0.31 4.27 0.41 29 0.153 25 0.315
Bold data indicate a significant difference versus the control group (P  0.05). % Change is in comparison with the control group.
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study, we were primarily interested in the imaging of the RNFL
of the peripapillary area; however, for more reliable measures
of the retinal ganglion cell layer and other layers, the parafoveal
area should also be imaged.
The S-pathway PhNR was reduced in open-angle glaucoma,
which agrees with findings in other studies of S-cone dysfunc-
tion.31,33–35 This result suggests that the defects of the blue-
sensitive mechanism occur at a later stage of the disease pro-
cess when ganglion cell death is present and is supported by
the fact that SWAP (short-wavelength automated perimetry)
results correlate with RNFL thickness measured by OCT in
patients with glaucoma.45 A nonsignificant reduction was
found for the S cone b-wave and PhNR for the OHT group
compared with the control group, contrary to the findings of
our previous study.32 The reduction of the mean amplitudes
for the b-wave and PhNR was 22% and 30%32 compared with
36% and 27%, respectively.
The highly significant correlation of the PERG P50-N95 with
the PhNR suggests a common origin for these potentials,
which is in general agreement with previous studies.31,32,46
The highly significant correlations found between the imaging
parameters, PERG amplitudes, and the L&M-pathway PhNR
imply a reproducible relationship between optic nerve head
tomography and retinal function. However, the modest corre-
lation coefficients (max r  0.37) suggest that this may not be
a linear relationship. These findings of modest correlation co-
efficient in patients with OHT or early stages of glaucoma are
in agreement with previous studies.47,48 Higher correlation
coefficients (r  0.60) have been found in open-angle glau-
coma with more advanced visual field loss.49,50
The lack of strong correlation coefficients found in our
study (r  0.50 for all) between the ERG and imaging param-
eters is not surprising. This weak correlation applied in partic-
ular to the subjects with OHT in whom attenuation of ERG
amplitudes indicated depressed retinal function in the absence
of significant changes in optic nerve head tomography (it is
interesting to note that FRT was reduced). If these changes in
retinal function were caused by ganglion cell dysfunction4
rather than cell death, then it is unlikely that optic nerve head
changes would be apparent, since these changes can occur
with preservation of the retinal ganglion cell axon.51 Our
findings are consistent with a report that the reduction in
retinal function (assessed by the PERG) for the central visual
field exceeded that expected from loss of retinal ganglion cells
(as assessed by OCT).52
Although our data are consistent with cell dysfunction, we
cannot rule out retinal ganglion cell loss that is undetectable by
HRT- and OCT-based structural measures. Since glial tissue can
remodel in response to axon loss, it can provide an offset to
any detectable reduction in RNFL thickness.53 The use of
higher resolution imaging techniques such as ultrahigh resolu-
tion OCT may resolve this issue.54
An intriguing finding is that subjects with treated OHT did
not show any difference in electrophysiological parameters
when compared with control subjects. By contrast, patients
with untreated OHT showed significant differences, as mea-
sured by PERG and PhNR. These observations raise the possi-
bility that some of the deficits associated with OHT are revers-
ible, and hence longitudinal studies in patients with OHT
before and after treatment are needed for confirmation.
The highly significant correlation between ERG amplitudes
and imaging parameters combined with only modest correla-
tion coefficients supports the view that structural changes to
the optic nerve head and the attenuation of ERG parameters
are occurring at different points in the pathologic process. Our
data are consistent with the hypothesis that retinal ganglion
cell dysfunction occurs before retinal ganglion cell death.
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